Pharmaceutical competitive intelligence. Winning strategies for biopharma from development through commercialization.

We help biopharma teams uncover threats, seize opportunities, and make strategic decisions with confidence. Our pharma competitive intelligence is grounded in primary research, real-time conference intelligence, and proprietary analytical tools.

How We Deliver Pharmaceutical Competitive Intelligence

Primary intelligence

Rapid KOL, market and industry stakeholder interviews, payer and patient research through QuickAnswers and custom engagements

Conference coverage

Before, during, and after major congresses (e.g. ASCO, ESMO, ASH, AHA, JPM) with previews, real-time tracking, and strategic debriefs

Wargames & workshops

AI-powered, human-in-the-loop, competitive simulations through LucidWargames, plus traditional facilitated workshops

Continuous monitoring: Competitive landscape tracking via proprietary tools, such as LucidScope and LucidSearch

Pharma Competitive Intelligence for Strategic Decision-Making

  • Asset Clinical Development and Commercialization
  • R&D and Pipeline Assets
  • Market Access
  • Pricing/Reimbursement
  • Regulatory Needs
  • Emerging Markets
  • Biosimilars/Generics
  • OTC Offerings
  • Digital Health

Pharma Competitive Intelligence Across the Drug Development Lifecycle

We support teams with pharma competitive intelligence from early product planning through brand development and mature product strategy.

  • Asset and Pipeline Development
  • Brand Planning
  • Mature Product Planning

Pharmaceutical Intelligence Across Therapeutic Areas

Our pharma competitive intelligence combines in-house expertise with a specialist network spanning key therapeutic areas, including oncology and hematology, rare diseases, immunology, neuroscience, respiratory, cardiovascular and metabolic diseases, infectious diseases and vaccines.

  • Oncology/Hematology (solid/liquid tumors etc.)
  • Gene and Cell Therapy / Rare Diseases (muscular dystrophy, ophthalmology, hemophilia etc.)
  • Inflammatory and Autoimmune Diseases (including rheumatology, dermatology, allergy, MS etc.)
  • Neurological Disorders (including epilepsy, Alzheimer’s, schizophrenia, PD etc.)
  • Respiratory Disorders (including asthma, COPD, IPF, PAH etc.)
  • Cardiovascular Disorders / Diabetes (including stroke, lipid disorders etc.)
  • Infectious Diseases / Vaccines (including HIV, HCV, flu, MRSA, RSV etc.)
  • Pain (including chronic pain, cancer-associated pain etc.)
  • Blood Disorders (e.g. hemophilia)

Build Competitive Intelligence That Compounds

(Powered by NexusBrain)

Every engagement generates valuable insight: KOL perspectives, congress observations, wargame scenarios, competitive assumptions. Too often, this intelligence lives in static reports and forgotten slide decks.

LucidQuest engagements can be integrated with NexusBrain (nexusbrain.io), a platform that captures, structures, and activates employee-driven and expert-validated intelligence. Primary research findings, conference observations from your own teams, and wargame outputs become a searchable, cumulative asset, not one-off deliverables.

The result: every engagement makes your organization’s intelligence sharper, and gives your AI tools better inputs to work with.

Learn more at nexusbrain.io

Ready to build winning competitive strategies?

Let’s accelerate your success together. Contact us at info@lqventures.com.

Rare Diseases Weekly News – June 5th 2025

Cell and Gene Therapy Weekly News – June 5th 2025

Cardiovascular Weekly News – June 5th 2025

Immunology Weekly News – June 4th 2025

Neuroscience Weekly News – June 4th 2025

Obesity Weekly News – June 3rd 2025

Endocrinology Weekly Update – June 3rd 2025

Artificial Intelligence and Digital Health Weekly News – June 2nd 2025

Oncology Weekly News – June 2nd 2025

Hematology Weekly News – June 2nd 2025

Public Health Weekly News – May 30th 2025

Privacy Preference Center